24小时热门版块排行榜    

查看: 2744  |  回复: 23
当前只显示满足指定条件的回帖,点击这里查看本话题的所有回帖

liuhongge1

木虫 (小有名气)


[交流] 帮我分析分析是否中稿呢

前段时间在IOP上投了篇文章,编辑回复如下:
Thank you for your submission which will be considered for publication in
*************. The
reference number for your article is ********. Please quote this number in
all future correspondence regarding this article.

还让填一份assignment of copyright

ASSIGNMENT OF COPYRIGHT and DECLARATION OF RESPONSIBILITY
1. IOP Publishing Ltd ("the Publisher" agrees to publish

Manuscript title: ********************* ("The Article" written by

Names of all Authors: ****************************("the Named Authors"

in the following journal: **********************("the Journal"

2. Transfer of Copyright Agreement
2.1 On acceptance for publication the undersigned author(s) (“Author”) of the Article assigns exclusively to IOP worldwide copyright in the Article for the full term and for all media and formats in all material published as part of the Article, which expression includes but is not limited to the text, abstract, tables, figures and graphs, but excludes any supplementary material.

2.2 If any of the Named Authors are Government employees, on acceptance for publication the Author shall grant IOP a royalty free exclusive licence for the full term of copyright for all media and formats to do in relation to the Article all acts restricted by copyright worldwide.

2.3 On acceptance for publication the Author shall grant IOP a royalty free non-exclusive licence for the full term of copyright for all media and formats to do in relation to any supplementary material deemed to be part of the Article all acts restricted by copyright worldwide.

3. Author Rights
3.1 IOP grants the Named Authors the rights specified in 3.2 and 3.3. All such rights must be exercised for non-commercial purposes, if possible should display citation information and IOP’s copyright notice, and for electronic use best efforts must be made to include a link to the on-line abstract in the Journal. Exercise of the rights in 3.3 additionally must not use the final published IOP format but the Named Author’s own format (which may include amendments made following peer review).

3.2 The rights are:

3.2.1 To make copies of the Article (all or part) for teaching purposes;

3.2.2 To include the Article (all or part) in a research thesis or dissertation;

3.2.3 To make oral presentation of the Article (all or part) and to include a summary and/or highlights of it in papers distributed at such presentations or in conference proceedings; and

3.2.4 All proprietary rights other than copyright.

3.3 The additional rights are to:

3.3.1 Use the Article (all or part) without modification in personal compilations or publications of a Named Author’s own works (provided not created by third party publisher);

3.3.2 Include the Article (all or part) on a Named Author’s own personal web site;

3.3.3 Include the Article (all or part) on web sites of the Institution (including its repository) where a Named Author worked when research for the Article was carried out; and

3.3.4 Include the Article (all or part) on third party web sites including e-print servers, but not on other publisher’s web sites.

Signature

In signing this Agreement the Author represents and warrants that the Article is the original work of the Named Authors, it has not been published previously in any form (other than as permitted under clause 3.2.2 which fact has been notified to IOP in writing), all Named Authors have participated sufficiently in the conception and writing of the Article, have received the final version of the Article, agree to its submission and take responsibility for it, and submission has been approved as necessary by the authorities at the establishment where the research was carried out.

The Author warrants that he/she signs this Agreement as authorised agent for all Named Authors and has the full power to enter into this Agreement and to make the grants it contains, that the Article has not been and will not be submitted to another publisher prior to withdrawal or rejection, it does not infringe any third party rights, it contains nothing libellous or unlawful, all factual statements are to the best of the Author’s knowledge true or based on valid research conducted according to accepted norms, and all required permissions have been obtained in writing.

All Named Authors assert their moral rights.

Author’s signature………………………………………....………….Date……………………

Signature on behalf of Institution………………………………………Date…………………….
回复此楼

» 猜你喜欢

» 本主题相关价值贴推荐,对您同样有帮助:

已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

liuhongge1

木虫 (小有名气)


引用回帖:
Originally posted by wait1986 at 2011-03-31 17:11:57:
不出意外是中了,恭喜恭喜!

希望是吧,耐心等待,谢谢
18楼2011-04-01 09:16:47
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖
查看全部 24 个回答

seaharrier

铁杆木虫 (知名作家)


liuhongge1(金币+1): 谢谢,是中了吗? 2011-04-01 09:06:17
引用回帖:
Originally posted by liuhongge1 at 2011-03-31 15:02:26:
前段时间在IOP上投了篇文章,编辑回复如下:
Thank you for your submission which will be considered for publication in
*************. The
reference number for your article is ********. Please quote ...

恭喜楼主!
2楼2011-03-31 15:48:33
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

袁海滨

新虫 (著名写手)


liuhongge1(金币+1): IOP的,Modelling Simul. Mater. Sci. Eng 2011-04-01 09:08:03
什么期刊啊?恭喜
3楼2011-03-31 16:13:08
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

wang0366

木虫 (小有名气)


liuhongge1(金币+1): 谢谢 2011-04-01 09:08:17
应该还没送审吧!有审稿意见吗?
4楼2011-03-31 16:19:31
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖
普通表情 高级回复 (可上传附件)
最具人气热帖推荐 [查看全部] 作者 回/看 最后发表
[文学芳草园] 梦想 +5 myrtle 2026-08-26 8/400 2026-09-02 02:42 by Leogzhya
[基金申请] 面上合作单位盖章 +6 ssyjh 2026-08-27 9/450 2026-09-01 20:01 by huagongfeihu
[基金申请] 为什么国自然不能直接公布 +5 bjdxyxy 2026-08-26 5/250 2026-09-01 17:54 by 小伟大博士
[论文投稿] 小白求助 投论文要求的highlights应该如何写 5+3 l1963982152 2026-08-29 4/200 2026-09-01 09:04 by 北京莱茵编辑
[基金申请] 怎么看青基中了没有啊 +6 叶九微 2026-08-26 6/300 2026-08-31 23:54 by yudaoqian88
[基金申请] 基金未中,这种答复是模板吗? +6 zhaosm1982 2026-08-27 7/350 2026-08-31 21:18 by qdxxmc
[基金申请] 面上意见出来了 +12 黄鸟于飞Chao 2026-08-29 23/1150 2026-08-31 18:57 by 黄鸟于飞Chao
[基金申请] 能否申诉? +7 echo8914667 2026-08-30 8/400 2026-08-31 17:00 by yihongxu
[基金申请] 中青基了要发朋友圈吗? +7 349506619 2026-08-28 7/350 2026-08-31 13:39 by 冼亮淀粉酶
[基金申请] 29号明天会评吗 +4 笨笨唐 2026-08-28 4/200 2026-08-31 09:30 by huixian257
[基金申请] 基金不中,共勉 +12 eulota 2026-08-26 12/600 2026-08-31 08:42 by ZJTJZ
[基金申请] 为什么到现在没收到通知? +5 tannykie 2026-08-29 5/250 2026-08-30 21:05 by purplejack
[基金申请] 我就是申请一个面上项目而已,这评审意见是按照杰青的条件评的吧? +6 gouxfjh 2026-08-28 11/550 2026-08-30 07:57 by gouxfjh
[基金申请] 国自然面上复盘~欢迎讨论 (金币+15) +15 晴天加油 2026-08-26 16/800 2026-08-29 18:28 by symmetry
[基金申请] 系统查不到 +11 董八千 2026-08-26 11/550 2026-08-28 18:06 by Leogzhya
[基金申请] 基金系统什么内容也没有 30+4 winsaint 2026-08-27 9/450 2026-08-28 11:06 by maolC
[基金申请] 出来了 +9 trojank 2026-08-26 9/450 2026-08-26 14:25 by 宝贝虫子
[基金申请] 国合里面能看到了 +7 一怀馨秋 2026-08-26 7/350 2026-08-26 11:23 by zhaosm1982
[基金申请] 系统进不去 +4 yanglien 2026-08-26 5/250 2026-08-26 11:10 by wenfengw83
[基金申请] 国合可查了 +3 paperzjh 2026-08-26 3/150 2026-08-26 10:41 by LemmonTr
信息提示
请填处理意见